Skip to main content

Resultados relacionados

Resultados totales (Incluyendo duplicados): 6
Encontrada(s) 1 página(s)

Dipòsit Digital de Documents de la UAB
Publication Artículo científico (JournalArticle)

Reversion of metabolic dysfunction-associated steatohepatitis by skeletal muscle-directed FGF21 gene therapy

  • Jimenez, Veronica|||0000-0001-9145-9877
  • Sacristan, Victor|||0000-0003-0356-0356
  • Jambrina Pallarés, Claudia|||0000-0002-9093-5568
  • Jaén Sitges, Maria Luisa|||0000-0002-9188-0810
  • Casaña Lorente, Estefania|||0000-0002-1353-5018
  • Muñoz-Martínez, S.|||0000-0003-0663-0575
  • Marcó, Sara|||0000-0003-3502-5198
  • Molas Laplana, Maria|||0000-0002-3215-515X
  • Garcia, Miquel|||0000-0002-1602-4993
  • Grass Costa, Ignasi|||0000-0002-6917-3271
  • León, Xavier|||0000-0002-8393-2721
  • Elias Puigdomenech, Ivet|||0000-0002-1304-9597
  • Ribera Sánchez, Albert|||0000-0002-7120-4276
  • Elias Bosch, Gemma|||0000-0003-1985-7955
  • Sánchez Clares, Víctor|||0000-0001-8631-9239
  • Vilà, Laia|||0000-0002-1211-5804
  • Casellas Comallonga, Alba|||0000-0003-0203-4733
  • Ferre, Tura|||0000-0001-9713-0829
  • Rodó Morera, Jordi|||0000-0001-8533-2597
  • Carretero i Romay, Ana|||0000-0001-9377-4926
  • Pumarola i Batlle, Martí|||0000-0002-0935-7941
  • Navarro Beltrán, Marc|||0000-0002-9678-6129
  • Andaluz Martínez, Anna|||0000-0001-8097-8110
  • Moll, Xavier|||0000-0002-2992-9361
  • Añor Torres, Sònia|||0000-0002-1099-7698
  • Franckhauser, Sylvie|||0000-0001-5255-1224
  • Vergara, Mercedes|||0000-0002-6971-8657
  • Caixàs i Pedragós, Assumpta|||0000-0001-8472-9189
  • Bosch i Tubert, Fàtima|||0000-0002-7705-5515
The highly prevalent metabolic dysfunction-associated steatohepatitis (MASH) is associated with liver steatosis, inflammation, and hepatocyte injury, which can lead to fibrosis and may progress to hepatocellular carcinoma and death. New treatment modalities such as gene therapy may be transformative for MASH patients. Here, we describe that one-time intramuscular administration of adeno-associated viral vectors of serotype 1 (AAV1) encoding native fibroblast growth factor 21 (FGF21), a key metabolic regulator, resulted in sustained increased circulating levels of the factor, which mediated long-term (.
Dipòsit Digital de Documents de la UAB
Publication Artículo científico (JournalArticle)

Rat models of musculoskeletal lysosomal storage disorders and their role in pre-clinical evaluation of gene therapy approaches

  • Marcó, Sara|||0000-0003-3502-5198
  • Muñoz Forero, Sergio Antonio|||0000-0001-6641-5004
  • Bosch i Tubert, Fàtima|||0000-0002-7705-5515
  • Jimenez, Veronica|||0000-0001-9145-9877
Mice have been a cornerstone of biomedical research for decades for studying a wide range of biological processes, disease mechanisms, and the assessment of therapies. Moreover, mice present several practical advantages such as small size, low cost and ease of genetic manipulation. While mice offer numerous benefits, for certain disease areas, rat models provide a closer representation of human disease progression, offering better insights for translational research and therapeutic development. This closer resemblance is particularly important for research focusing on diseases involving the cardiovascular and musculoskeletal system. In rats, the pathophysiology of these diseases mirrors the clinical alterations observed in humans. This review focuses on the key phenotypic differences between mouse and rat models of lysosomal storage disorders that specifically manifest with cardiac, skeletal muscle, and bone and joint involvement (Pompe and Danon diseases, and Maroteaux-Lamy and Morquio A syndromes). Furthermore, we discuss the therapeutic potential of various adeno-associated viral vector-mediated gene therapies that have been evaluated in these rat models, highlighting their contributions to advancing treatment options for these debilitating conditions.
Dipòsit Digital de Documents de la UAB
Publication Artículo científico (JournalArticle)

A myotropic AAV vector combined with skeletal muscle cis-regulatory elements improve glycogen clearance in mouse models of Pompe disease

  • Sellier, P.
  • Collaud, F.
  • Benchekroun, Y. Krimi
  • Jimenez, Veronica|||0000-0001-9145-9877
  • Leon, X.
  • Daniele, N.
  • Pham, Q. H.
  • El Andari, J.
  • VandenDriessche, T.
  • Chuah, M. K.
  • Grimm, D.
  • Bosch Albareda, Francesc|||0000-0001-9241-2886
  • Mingozzi, F.
  • Ronzitti, G.
Pompe disease is a glycogen storage disorder caused by mutations in the acid alpha-glucosidase (GAA) gene, leading to reduced GAA activity and glycogen accumulation in heart and skeletal muscles. Enzyme replacement therapy with recombinant GAA, the standard of care for Pompe disease, is limited by poor skeletal muscle distribution and immune responses after repeated administrations. The expression of GAA in muscle with adeno-associated virus (AAV) vectors has shown limitations, mainly the low targeting efficiency and immune responses to the transgene. To address these issues, we developed AAV capsids with improved skeletal muscle targeting and reduced off-targeting. These capsids combined with codon optimization, muscle-specific cis-regulatory elements, and a synthetic promoter demonstrated a strong skeletal muscle tropism, reduced liver targeting, and enhanced GAA trans-gene expression and reduced glycogen accumulation in a Gaa-/- mouse model. However, increased muscle-specific expression led to a robust anti-hGAA immune response. To circumvent this, the AAVMYO2 capsid was tested in immunodeficient Gaa-/-Cd4-/- mice and compared to AAV9 at different doses. The combination of AAVMYO2 with an optimized transgene expression cassette provided a dose-dependent advantage for glycogen reduction in skeletal muscles of Gaa-/- Cd4-/- mice. These findings support the potential of muscle-specific AAV gene therapy for Pompe disease at lower doses with greater specificity.
Dipòsit Digital de Documents de la UAB
Publication Artículo científico (JournalArticle)

BMP7 overexpression in adipose tissue induces white adipogenesis and improves insulin sensitivity in ob/ob mice

  • Casaña Lorente, Estefania|||0000-0002-1353-5018
  • Jimenez, Veronica|||0000-0001-9145-9877
  • Sacristan, Victor|||0000-0003-0356-0356
  • Muñoz-Martínez, S|||0000-0003-0663-0575
  • Jambrina Pallarés, Claudia
  • Rodó Morera, Jordi|||0000-0001-8533-2597
  • Garcia, Miquel|||0000-0002-1602-4993
  • Mallol, Cristina|||0000-0002-2920-9612
  • León, Xavier|||0000-0002-8393-2721
  • Franckhauser, Sylvie|||0000-0001-5255-1224
  • Bosch i Tubert, Fàtima|||0000-0002-7705-5515
Background/objectives: During obesity, hypertrophic enlargement of white adipose tissue (WAT) promotes ectopic lipid deposition and development of insulin resistance. In contrast, WAT hyperplasia is associated with preservation of insulin sensitivity. The complex network of factors that regulates white adipogenesis is not fully understood. Bone morphogenic protein 7 (BMP7) can induce brown adipogenesis, but its role on white adipogenesis remains to be elucidated. Here, we assessed BMP7-mediated effects on white adipogenesis in ob/ob mice. Methods: BMP7 was overexpressed in either WAT or liver of ob/ob mice using adeno-associated viral (AAV) vectors. Analysis of gene expression, histological and morphometric alterations, and metabolites and hormones concentrations were carried out. Results: Overexpression of BMP7 in adipocytes of subcutaneous and visceral WAT increased fat mass, the proportion of small-size adipocytes and the expression of adipogenic and mature adipocyte genes, suggesting induction of adipogenesis irrespective of fat depot. These changes were associated with reduced hepatic steatosis and improved insulin sensitivity. In contrast, liver-specific overproduction of BMP7 did not promote WAT hyperplasia despite BMP7 circulating levels were similar to those achieved after genetic engineering of WAT. Conclusions: This study unravels a new autocrine/paracrine role of BMP7 on white adipogenesis and highlights that BMP7 may modulate WAT plasticity and increase insulin sensitivity.
Dipòsit Digital de Documents de la UAB
Publication Artículo científico (JournalArticle)

AAV-mediated BMP7 gene therapy counteracts insulin resistance and obesity

  • Casaña Lorente, Estefania|||0000-0002-1353-5018
  • Jimenez, Veronica|||0000-0001-9145-9877
  • Jambrina Pallarés, Claudia|||0000-0002-9093-5568
  • Sacristan, Victor|||0000-0003-0356-0356
  • Muñoz-Martínez, S.|||0000-0003-0663-0575
  • Rodo, Jordi
  • Grass Costa, Ignasi|||0000-0002-6917-3271
  • Garcia, Miquel|||0000-0002-1602-4993
  • Mallol, Cristina|||0000-0002-2920-9612
  • León, Xavier|||0000-0002-8393-2721
  • Casellas Comallonga, Alba|||0000-0003-0203-4733
  • Sánchez Clares, Víctor|||0000-0001-8631-9239
  • Franckhauser, Sylvie|||0000-0001-5255-1224
  • Ferre, Tura|||0000-0001-9713-0829
  • Marcó, Sara|||0000-0003-3502-5198
  • Bosch i Tubert, Fàtima|||0000-0002-7705-5515
Type 2 diabetes, insulin resistance, and obesity are strongly associated and are a major health problem worldwide. Obesity largely results from a sustained imbalance between energy intake and expenditure. Therapeutic approaches targeting metabolic rate may counteract body weight gain and insulin resistance. Bone morphogenic protein 7 (BMP7) has proven to enhance energy expenditure by inducing non-shivering thermogenesis in short-term studies in mice treated with the recombinant protein or adenoviral vectors encoding BMP7. To achieve long-term BMP7 effects, the use of adeno-associated viral (AAV) vectors would provide sustained production of the protein after a single administration. Here, we demonstrated that treatment of high-fat-diet-fed mice and ob/ob mice with liver-directed AAV-BMP7 vectors enabled a long-lasting increase in circulating levels of this factor. This rise in BMP7 concentration induced browning of white adipose tissue (WAT) and activation of brown adipose tissue, which enhanced energy expenditure, and reversed WAT hypertrophy, hepatic steatosis, and WAT and liver inflammation, ultimately resulting in normalization of body weight and insulin resistance. This study highlights the potential of AAV-BMP7-mediated gene therapy for the treatment of insulin resistance, type 2 diabetes, and obesity. HFD-fed and ob/ob mice treated with liver-directed AAV-BMP7 vectors showed increased serum BMP7, which induced energy expenditure and reversed WAT hypertrophy, hepatic steatosis, and WAT and liver inflammation, resulting in body weight normalization and insulin sensitivity. This study highlights the potential of AAV-BMP7-mediated gene therapy to treat insulin resistance and obesity.
Dipòsit Digital de Documents de la UAB
Publication Artículo científico (JournalArticle)

Integrated gene expression profiles reveal a transcriptomic network underlying the thermogenic response in adipose tissue

  • Rodó Morera, Jordi|||0000-0001-8533-2597
  • Garcia, Miquel|||0000-0002-1602-4993
  • Casaña Lorente, Estefania|||0000-0002-1353-5018
  • Muñoz-Martínez, S|||0000-0003-0663-0575
  • Jambrina Pallarés, Claudia
  • Sacristan, Victor|||0000-0003-0356-0356
  • Franckhauser, Sylvie|||0000-0001-5255-1224
  • Grass Costa, Ignasi|||0000-0002-6917-3271
  • Jimenez, Veronica|||0000-0001-9145-9877
  • Bosch i Tubert, Fàtima|||0000-0002-7705-5515
Obesity and type 2 diabetes are two closely related diseases representing a serious threat worldwide. An increase in metabolic rate through enhancement of non-shivering thermogenesis in adipose tissue may represent a potential therapeutic strategy. Nevertheless, a better understanding of thermogenesis transcriptional regulation is needed to allow the development of new effective treatments. Here, we aimed to characterize the specific transcriptomic response of white and brown adipose tissues after thermogenic induction. Using cold exposure to induce thermogenesis in mice, we identified mRNAs and miRNAs that were differentially expressed in several adipose depots. In addition, integration of transcriptomic data in regulatory networks of miRNAs and transcription factors allowed the identification of key nodes likely controlling metabolism and immune response. Moreover, we identified the putative role of the transcription factor PU.1 in the regulation of PPARγ-mediated thermogenic response of subcutaneous white adipose tissue. Therefore, the present study provides new insights into the molecular mechanisms that regulate non-shivering thermogenesis.